FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed group of inventions relates to medicine, namely to neurology, and deals with treating dementia. For this purpose an effective amount of a compound, possessing the activity of an agonist of 5-HT4-receptors - N-((1-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)piperidin-4-yl)methyl)-3-isopropyl-2-oxo-2,3-dihydro-1H-benzo[d]imodazole-1-carboxamide is introduced.
EFFECT: medication provides an improvement of the cognitive function and the reduction of the level of the beta-amyloid peptide in case of neurodegenerative diseases.
9 cl, 4 ex, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2632193C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2629118C2 |
BENZOFURAN DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINE | 2016 |
|
RU2727198C2 |
PYRAZOLO[3,4-b]PURIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION (VERSIONS), APPLICATION (VERSIONS), COMBINATION (VERSIONS) | 2003 |
|
RU2357967C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
IMIDAZOTRIAZINONE COMPOUNDS | 2011 |
|
RU2603140C2 |
HETEROCYCLIC COMPOUND | 2018 |
|
RU2791533C2 |
IMIDAZOPYRAZINE OR IMIDAZODIAZEPINE DERIVATIVES, ACTIVE WITH RESPECT TO RECEPTOR CB2 | 2008 |
|
RU2540074C2 |
TREATMENT METHOD | 2012 |
|
RU2621148C2 |
Authors
Dates
2015-11-27—Published
2011-02-14—Filed